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Abstract
Background: The mass availability and use of mobile health (mHealth) technologies offers the potential for these technologies
to support or substitute medical advice. However, it is worrisome that most assessment initiatives are still not able to successfully
evaluate all aspects of mHealth solutions. As a result, multiple strategies to assess mHealth solutions are being proposed by
medical regulatory bodies and similar organizations.
Objective: We aim to offer a collective description of a universally applicable description of mHealth assessment initiatives,
given their current and, as we see it, potential impact. In doing so, we recommend a common foundation for the development or
update of assessment initiatives by addressing the multistakeholder issues that mHealth technology adds to the traditional medical
environment.
Methods: Organized by the Mobile World Capital Barcelona Foundation, we represent a workgroup consisting of patient
associations, developers, and health authority representatives, including medical practitioners, within Europe. Contributions from
each group’s diverse competencies has allowed us to create an overview of the complex yet similar approaches to mHealth
evaluation that are being developed today, including common gaps in concepts and perspectives. In response, we summarize
commonalities of existing initiatives and exemplify additional characteristics that we believe will strengthen and unify these
efforts.
Results: As opposed to a universal standard or protocol in evaluating mHealth solutions, assessment frameworks should respect
the needs and capacity of each medical system or country. Therefore, we expect that the medical system will specify the content,
resources, and workflow of assessment protocols in order to ensure a sustainable plan for mHealth solutions within their respective
countries.
Conclusions: A common framework for all mHealth initiatives around the world will be useful in order to assess whatever
mHealth solution is desirable in different areas, adapting it to the specifics of each context, to bridge the gap between health
authorities, patients, and mHealth developers. We aim to foster a more trusting and collaborative environment to safeguard the
well-being of patients and citizens while encouraging innovation of technology and policy.
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Introduction
Mobile health (mHealth) is defined by the World Health
Organization’s (WHO) Global Observatory for eHealth as
“medical and public health practice supported by mobile devices,
such as mobile phones, patient monitoring devices, personal
digital assistants (PDAs), and other wireless devices” [1].
Despite the lack of safety and quality validation of these
technologies by medical regulatory bodies, individuals have
adopted mHealth devices as self-management aids, while
medical professionals are at a loss for how to relate to them [1].
Due to this consumer-based and rapid introduction within the
world of patient health aids, mHealth solutions present unique
and stakeholder-specific challenges to the medical environment.
Patients, health care providers, administrators, authorities, and
mHealth developers alike are operating without clear
direction—from potentially improper use of mHealth apps by
individuals, to medical systems’ inability to react due to lack
of technological and organizational support. Therefore, several
questions arise: How should health authorities approach mHealth
evaluation and certification? How can this be accomplished
without stifling innovation? Should efforts to determine risks,
benefits, and appropriate use be held on a global, country, or
regional basis? How will policies and strategies be introduced
to medical professionals and their practices? Which methods
should be used to ensure that patients are properly informed on
how to select and use mHealth solutions?
Today, there are many efforts underway to address these
challenges [2-5]. However, these are happening in silos and are
often specific to a single country or medical system. In this
paper, we explore the progress and setbacks of the mHealth
assessment environment and propose a collaborative and global
approach to assessment, with the aim of applying the
competencies of all stakeholder groups. We believe that by
structuring our work in this field from a common foundation,
assessment initiatives can and will foster a more trusting and
collaborative environment to safeguard the well-being of citizens
while encouraging innovation of technology and policy.
The purpose of this viewpoint paper is to be informative and
provocative, focusing on the changes in mindset and actions
that must occur—from the education and perspective of
consumers, health assessment evaluations teams, and medical
authorities—in the assessment of mHealth solutions. As such,
we hope to elicit discussion on the content and methodologies
of our suggested common framework for mHealth assessment.
The Potential of Mobile Technologies in
the Medical Field
The potential of mHealth solutions lies in their ability to enable
chronic diseases management and general wellness motivation
[6-8]. By tracking an individual’s health and lifestyle data, and
by providing actionable feedback, these tools encourage
self-management. With the subsequent promise of equipping
health care providers with such detailed information about a
patient’s health status in relation to their daily habits, the medical
system could not only better understand elusive compliance
issues but also propose tailored solutions [9] for individual
patients. If integrated and supported appropriately, these tools
could improve treatment, empower patients, and foreseeably
lower medical costs and streamline use of health care resources
[10,11].
However, because these innovations are diverse and
unstandardized, mHealth requires that regulatory bodies take a
fresh look at evaluation methodologies for health aids. Today,
medical actors are expected to adapt to the rapid technology
turnover, ubiquity, and connectivity of mHealth by collecting,
incorporating, and analyzing unprecedented amounts of personal
health information seamlessly within the clinical environment.
However, medical research and validation protocols, which
providers rely on for guidance, are currently unable to adapt as
quickly as such mHealth tools are being released. As a result,
health care providers are left in the dark regarding how to relate
to mHealth tools, as well as the impacts to their own professional
responsibilities. If this goes un-checked, the medical system
will continue to lag behind the needs of its patients.
The Current Situation
Just as in the proverbial scenario of the Band-Aid on the leaking
dam, the mHealth environment has been met with a series of
incomplete or issue-specific solutions to the evaluation of health
apps, wearables and sensors. In fact, neither the Health
Technology Assessment (HTA) agency [12] nor its collaborative
networks, European Network for Health Technology Assessment
(EUnetHTA) and HTA Network, have tackled mHealth solutions
within their range of technology assessments. As patients
continue to use these apps regardless of clinical support or
guidance, health authorities and providers fall further behind,
stuck in the traditional and hypercontrolled operations of the
medical sector. With good intentions, organizations continuously
attempt to address the distinct issues facing patients and
clinicians. Promising attempts included the National Health
Service’s Health Apps Library [13], which aimed to involve
clinicians in the review process, yet it is still under maintenance;
the Organization for the Review of Care and Health Applications
[14], which describes the purpose of their value and risk scores
but not which features of an app lead to its value or risk; and
PatientView’s “The myhealthapps directory 2015-2016” [15],
which presented a summary of consumer-generated app reviews.
While these initiatives attempt to provide the public with
digestible and relevant information, they simply add to the slew
of disjointed and static solutions that are not able to address all
stakeholder issues.
A Step in the Right Direction
Recently, governmental organizations and those representing
end-user interests have acknowledged that flexible solutions
and continuous communication are more appropriate for the
mHealth environment than customary static reports. A
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preparatory review of these evaluation initiatives illustrates the
range of developed mHealth evaluation methodologies and
adapted health assessment frameworks for use in mHealth.
These initiatives focus mainly on the usability and clinical
application of mHealth technologies, which are most commonly
provided by individual user's commentaries, the organization’s
own evaluation team or, very rarely, a representative group of
medical practitioners [16-19]. Some, including the United States
Food and Drug Administration (FDA), choose to regulate only
devices that fall under the definition of “medical device,”
enabling them to rely on existing frameworks for evaluation
and implementation [20]. Others attempt to address a broader
range of tools, with some focusing only on risk assessment
[21,22] or even utilizing nontraditional resources (eg, novel
technologies and social media outlets [23]) to evaluate mHealth
solutions. Finally, most initiatives address only mHealth
solutions that are fully operational within the market [24], with
no solution for those under development [25].
Too Many Initiatives, Too Few Answers
Despite the diversity of approaches, recent reviews reveal
worrisome results—a lack of conclusive or actionable evidence
to suggest the ability of commercially available mHealth tools
to effect behavioral changes or to manage chronic diseases,
inpatient care, or health care delivery [26]. As a result, a primary
concern and unfortunate reality is that this environment has
allowed for the existence of misinformation regarding
appropriate uses for these mHealth solutions. Common labels
may even clearly categorize an app as “medical” yet include
the warning in fine print that the app is “intended for
entertainment only” [27]. Moreover, these evaluation efforts do
not involve or inform all stakeholders [28] of relevant results,
including potential risks associated with misleading health
recommendations or software failures.
To compare the scope of structure and insights offered by
today’s mHealth evaluation initiatives to the desired coverage
and impact that we believe is possible, we have completed a
comparative summary of representative evaluation efforts (see
Multimedia Appendix 1 [29-33]). These characteristics are in
addition to the assumed basic coverage of usability and security.
Such a lack of flexible and inclusive evaluation options has
resulted in a lack of empirically demonstrated understanding of
the benefits and risks that mHealth solutions provide to care
delivery and health management. There is clearly a need to
create an environment that explores additional options for
mHealth evaluation. For example, individuals outside the
medical realm have not traditionally had a majority voice in the
assessment of health aids. Yet today, individual app users are
becoming more knowledgeable about the daily benefits of
mHealth and technology developers are exploring the potential
of ever-present self-management systems. Therefore, we should
consider these groups as underutilized resources—we have an
opportunity to recognize and enthusiastically encourage the
insight that these individuals can now contribute to mHealth
evaluation efforts.
The Unsung Role of Developers in Assessment
Developers are the key force driving the need for certification
due to the astounding rate at which they are producing mHealth
solutions [34]. Therefore, those who are developing mHealth
solutions should be encouraged to seek assessment for their
own technologies through engagement in the evaluation process.
Additionally, they should be provided with guidance and
educational resources, including explanation of the concepts
and benefits of a quality assured and reliable product go
hand-in-hand with growth in the market and success, as the
result of consumer engagement, loyalty, and trust [35,36]. By
creating a mutually beneficial situation for developers and the
medical system, evaluation frameworks can facilitate an
environment that is transparent, trustworthy, and safe for users.
It must also be noted that we must achieve a balance between
development oversight and creative freedom. Too much
regulation, or an unnecessarily lengthy process, would paralyze
certification and inhibit adoption of mHealth solutions, which
is evident from responses to the US FDA’s complex and unclear
rulings [37]. Therefore, involving developers in the improvement
and operation of any mHealth assessment initiatives will ensure
the safety of their creativity and the competitive, open health-app
market.
The Need to Work From a Common
Foundation
While the resources, evidence, and financial support for clinical
implementation undoubtedly vary between countries and medical
systems, there are shared challenges and themes for assessment.
By acknowledging and addressing these common needs, we as
a health care community can work in parallel as opposed to
reinventing the wheel. Furthermore, these needs cannot hope
to be addressed by a single organization or single perspective
(eg, safety and privacy vs usability and consumer cost). The
needs presented by the mHealth assessment arena can be met
only through participation of all stakeholders, hand-in-hand
with regulation and legislation, constantly adapting to updates
in standards and the capacity of technology.
To facilitate the success of this collaborative approach, we must
simultaneously change the paradigm of evaluation to more
appropriately relate to the particularities of mHealth. As such,
it must be continuous and iterative, while at the same time
provide timely conclusions and actionable recommendations
for improvement and implementation.
Acknowledging and Merging Universal
Needs: Approaching the Solution
Together
Organized by the Mobile World Capital Barcelona Foundation,
the co-authors of this paper represent a workgroup of several
international partners with distinct yet complementary
backgrounds and competencies related to mHealth, including
patient groups, government, and health authorities, as well as
representatives from health research, care providers, and
technology developer groups. Exploration of the common needs
and themes of mHealth has resulted in a summative list of
concepts that we believe are universal to all assessment
initiatives. We welcome interested parties and future partners
to contribute their competencies and applicable solutions toward
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the future development of common and foundational guidelines
for building mHealth assessment frameworks. Not only are
newly validated tools needed in order to improve the quality of
assessment steps, but also the perspectives of a diverse group
of representatives in all affected fields. The following sections
outline the major universal concepts and approaches that can
inform proposed and existing evaluation initiatives.
Assigning the Evaluation Team
The concept of specialization is a key component in any effort
to impact a multistakeholder system. A single organization
cannot be expected to accomplish the diversity of tasks and
successfully address the challenges of mHealth evaluation (eg,
results of safety, usability, and health change assessments).
Therefore, representative organizations should be involved in
tasks associated with their competencies, thus providing even
distribution of responsibilities as well as relevant input.
In order to achieve a comprehensive process, the evaluation
team should possess a broad scope of perspectives that are
representative of the following stakeholder groups: patients or
patient organizations; commercial and research-based mHealth
developers; health care providers, medical professionals, and
system administrators; insurance or other reimbursement bodies;
and authorities within governmental health and medical system
organizations.
It is assumed that the composition of this team, and specific
roles of stakeholder representatives, will vary based on the
decision of each country or region that chooses to adopt and
adapt this approach to their own respective medical system.
Pre-Assessment of mHealth Solutions
The pre-assessment phase is meant to classify any mHealth app
and can be based on, for example, the following criteria: (1)
Risk classification matrix: combining intervention type and
patient type (see Figure 1 [38] for an example); (2) Users:
patients, medical professionals, and/or informal caregivers; and
(3) Integration: stand-alone, partially integrated, or fully
integrated.
In order to address mHealth solutions within any stage of
development, pre-assessment guides should be distributed to
developers who are still in the process of designing health
solutions as well as for members of evaluation teams within
any medical system or country.
Figure 1. Risk assessment matrix.
Checklists
Together with the pre-assessment phase, checklists can act as
preparative resources for the evaluation teams to ensure that all
relevant information is provided before resources and time are
spent assessing an mHealth solution, as well as subsequent
public and medical integration. Once pre-assessment has been
established, checklists can be directed toward each contextual
category of health apps. The checklist will vary from country
to country and be provided to the evaluation team. To illustrate
this point, a checklist should ensure that documentation related
to the following categories is provided for each mHealth
solution:
• designation of mHealth solutions by intended use, for
example, reference guides (eg, for nutrition or weight
control), monitoring devices (eg, for blood sugars or blood
pressure), or other types of solutions within a matrix
• level of development
• security and privacy
• interoperability standards
• usability
• functionalities and content
To the best of our knowledge, there are few functional and
representative checklists (eg, Catalonia, Andalucía, and WHO’s
mHealth Technical Evidence Review Group [29,39,40]). Most
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others are not fully available, are under development (eg,
European Commission mHealth assessment working group [5]),
or are focused only on mobile medical devices (eg, Future
Internet-STAR checklist model [41]). These checklists propose
categories related to functionality including usability,
technology, security, content design and pertinence, and
services. They also propose more domains related to
infrastructure, including intervention delivery, accessibility
toward individuals (ie, barriers or facilitators to the adoption of
the intervention among study participants), cost assessment,
adoption inputs/program entry, limitations for delivery at scale,
contextual adaptability, and replicability. Many of these
approaches involve classification of information into levels,
from mandatory to not applicable, based on the app’s level of
risk, thereby providing flexibility to assess not only medical but
also nonmedical devices.
Again, each stakeholder representative within evaluation teams
should be assigned to the topics they are most capable of
assessing. However, not all of these available checklists are
accessible or usable by all stakeholders. As previously
mentioned, developers are a key stakeholder in the success of
assessment initiatives. Therefore, all developers should be able
to provide the checklist information themselves. An alternative
and more time-consuming option is that facilitators be put in
place to gather this information from multiple sources in order
to answer evaluation questions. This will affect the level of time
and funded investment needed, which supports the involvement
and support of developer groups in the design of checklists.
mHealth Evaluation Aspects and Methods
Assessment initiatives must be equally focused on summative
(ie, during or post implementation) as well as formative
(throughout the development life cycle) evaluation. This will
ensure that not only common software development life-cycle
stages but also end-user needs and input are incorporated, thus
giving any initiative practical dimension. We expect that in
doing so, this will promote adoption by the app development
community as well as those representing the interests of the
medical community.
The categories of information provided by checklists can be
evaluated with the common evaluation perspectives of technical
readiness and maturity, risks, benefits, and resources needed.
The limitations and specifics of what is involved in these
evaluation domains should correspond to the purpose of the
evaluation (ie, assessing a device as an educational or medical
tool) and should vary depending on the level of interoperability
and intended use (eg, disease self-management vs activity
tracking) of the mHealth solution (eg, stand-alone app vs
integrated medical device).
Each of these four domains and their subdomains should be
defined to streamline evaluation efforts and organize stakeholder
participation based on their respective competencies (see
Multimedia Appendix 2 for an example). Ideally, the chosen
set of domains and subdomains should address the following
needs:
• Determine the appropriate use of each mHealth solution
(ie, as a medical device or a health and wellness tool, based
on the target and breadth of functionalities as well as status
of interoperability and safety standards)
• Develop expedited and conclusive methods to evaluate the
effect(s) that an mHealth solution has on respective clinical
outcomes and/or patient lifestyle habits, based on its
appropriate and intended use
• Assess risk related to (1) patients and their caregivers in
relation to personal data security, self-management decision
making, and disease understanding; (2) clinicians, including
liability to their practice and a greater trust of and reliance
on patient-gathered data; and (3) overall health care
organizations and systems, including financial impact and
liabilities
• Inform stakeholders of relevant results through respective
and accessible platforms.
Quantitative or qualitative methodologies may be employed
through formal evaluation studies (eg, clinical trials) to assess
each of these. The evaluation studies should be conducted based
on the regulations, practices, and implementation strategies of
individual countries or medical systems in which such studies
are completed. However, to our knowledge, most of the
subdomains still lack validated, standardized, or descriptive
approaches and methods for evaluation. Therefore, alternative
or unconventional inquiry methods should be considered
including involvement of medical education programs as well
as clinical and commercial research organizations, all of which
use complementary methods such as online platforms, market
analysis, and user-involved workshops. Partnership with
organizations that are able to develop such novel methods should
be sought both within the international realm of health sciences
and then adapted to the needs and socioeconomic factors present
within each unique medical system.
Conclusions
There is a clear need for defining a standard assessment
framework for mHealth technologies that will help separate the
wheat from the chaff and identify those solutions that may
provide added value to patients and the health care system. By
accomplishing this set of methodologies and approaches to
evaluation and also the methods, perspectives, and resources
used to accomplish these tasks, evaluation would facilitate more
educated and informed decision making regarding the choice
and use of mHealth solutions—from patients to medical
practitioners to the health authorities that are charged with
maintaining the foundation of each medical service.
The insights and suggestions provided in this paper are intended
for the groups that are completing evaluations, developing apps,
and creating health policy and infrastructural support for
mHealth implementation. We propose that all organizations and
individuals who share a similar passion for a coordinated effort
towards a more rigorous and comprehensive evaluation of
mHealth technologies join forces to form a virtual community
of practice [42]. Discussing the merits and shortcomings of the
proposed approach in this paper and its utility in real-world
scenarios can be a starting point for such community. We hope
that a free-flowing format will foster creative ways to solve the
problems put forward in this position paper. A social
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media‒based discussion group is a feasible starting point for
this virtual community of practice. The authors invite the experts
in evaluation of health information systems to provide their









Presence of desirable characteristics within existing mHealth assessment initiatives.
[PDF File (Adobe PDF File), 82KB - mhealth_v5i5e60_app1.pdf ]
Multimedia Appendix 2
Example set of domains and subdomains for an mHealth assessment framework.
[PDF File (Adobe PDF File), 327KB - mhealth_v5i5e60_app2.pdf ]
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